by Nathaniel Harding | Nov 2, 2023 | Blog
At Cortado Ventures, we back entrepreneurs that are inventing the future, and we are thrilled about our investment in Moat Biotechnology. Moat’s technology is based on a next-generation adenovirus platform from the Mayo Clinic. Our General Partner Mike Moradi...
by Nathaniel Harding | Oct 19, 2023 | Newsletters
In this month’s Doubleshot Newsletter, you will find: Builder Highlight: Northwest Arkansas Technology Summit Team Highlight: EIR Deborah Moorad accepts new role PortCo News Cortado News Ecosystem News & Events Builder Highlight: Northwest Arkansas Technology...
by Nathaniel Harding | Oct 18, 2023 | Podcasts
The Dos Equis marketing department misfired when they chose someone else for their Most Interesting Man in World campaign. Coming from a family with humble beginnings and developing a distaste for formal education throughout childhood, Scott Klososky blazed his own...
by Nathaniel Harding | Oct 11, 2023 | Blog
FOR IMMEDIATE RELEASE Oct. 11, 2023 Contact: Anthony Triana atriana@saxum.com (Direct) 405.818.0791 Cortado Ventures Invests in Teren, Inc.: Advancing Data-Driven Solutions for Climate and Terrain Risk Assessment OKLAHOMA CITY – Cortado Ventures, an early-stage...
by Nathaniel Harding | Sep 25, 2023 | Blog
AltAssets: Hefty exits help Cortado Ventures score huge fund size increase for sophomore raise Wall Street Journal VC Pro: VC Daily: What the New IPOs Mean for Late-Stage Market; Instacart Pops StrictlyVC: Musk gets probed, Neuralink searches for recruits, and...
